Cardiovascular and neurological toxicity of venlafaxine

被引:43
作者
Blythe, D
Hackett, LP
机构
[1] Sir Charles Gairdner Hosp, Intens Care Unit, Perth, WA 6009, Australia
[2] Western Australian Ctr Pathol & Med Res, Clin Pharmacol & Toxicol Lab, Perth, WA 6009, Australia
关键词
venlafaxine; cardiotoxicity; neurotoxicity; pharmacokinetics;
D O I
10.1191/096032799678840165
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1 We report a case of venlafaxine overdose and describe pharmacokinetic data on drug disposition. 2 Case report. Serial venlafaxine levels were measured and drug half-life calculated and compared to data at therapeutic concentrations. Metabolite concentrations were also measured and the potential for toxicity described with reference to individual variation in such metabolism 3 Venlafaxine can cause significant cardiac and neurotoxicity. Its potential for causing such toxicity may be dependent on whether an individual has the extensive metaboliser cytochrome CYP2D6 phenotype or the poor metaboliser phenotype.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 21 条
[11]   Two fatal cases of venlafaxine poisoning [J].
Parsons, AT ;
Anthony, RM ;
Meeker, JE .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1996, 20 (04) :266-268
[12]   Serotonin syndrome in combined moclobemide and venlafaxine ingestion [J].
Roxanas, MG ;
Machado, JFD .
MEDICAL JOURNAL OF AUSTRALIA, 1998, 168 (10) :523-524
[13]   The safety and tolerability of venlafaxine hydrochloride: Analysis of the clinical trials database [J].
Rudolph, RL ;
Derivan, AT .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (03) :S54-S59
[14]   PHARMACODYNAMICS OF VENLAFAXINE EVALUATED BY EEG BRAIN MAPPING, PSYCHOMETRY AND PSYCHOPHYSIOLOGY [J].
SALETU, B ;
GRUNBERGER, J ;
ANDERER, P ;
LINZMAYER, L ;
SEMLITSCH, HV ;
MAGNI, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (06) :589-601
[15]  
SCHWEIZER E, 1994, J CLIN PSYCHIAT, V55, P104
[16]  
SETZER SC, 1995, CLIN TOXICOL, V33, P496
[17]   THE EFFECT OF RENAL-DISEASE ON THE DISPOSITION OF VENLAFAXINE [J].
TROY, SM ;
SCHULTZ, RW ;
PARKER, VD ;
CHIANG, ST ;
BLUM, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (01) :14-21
[18]   THE PHARMACOKINETICS OF VENLAFAXINE WHEN GIVEN IN A TWICE-DAILY REGIMEN [J].
TROY, SM ;
PARKER, VD ;
FRUNCILLO, RJ ;
CHIANG, ST .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (04) :404-409
[19]   PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE POTENTIAL-DRUG INTERACTION BETWEEN VENLAFAXINE AND DIAZEPAM [J].
TROY, SM ;
LUCKI, I ;
PEIRGIES, AA ;
PARKER, VD ;
KLOCKOWSKI, PM ;
CHIANG, ST .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (04) :410-419
[20]   Seizure resulting from a venlafaxine overdose [J].
White, CM ;
Gailey, RA ;
Levin, GM ;
Smith, T .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) :178-180